These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3500754)

  • 21. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
    Lembersky BC; Ratain MJ; Westbrook C; Golomb HM
    Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remission in hairy cell leukaemia achieved with pentostatin.
    Spiers AS; Parekh SJ
    Lancet; 1984 May; 1(8385):1080-1. PubMed ID: 6144012
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
    Ho AD; Ganeshaguru K; Knauf WU; Dietz G; Trede I; Hunstein W; Hoffbrand AV
    Blood; 1988 Dec; 72(6):1884-90. PubMed ID: 3264192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
    Spiers AS
    Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the choice of treatment for hairy cell leukemia?
    Golomb HM; Ratain MJ; Moormeier J
    J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
    Daenen S; Rojer RA; Smit JW; Halie MR; Nieweg HO
    Br J Haematol; 1984 Dec; 58(4):723-7. PubMed ID: 6097297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
    Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials in hairy cell leukemia. Current status and future directions.
    Cheson BD; Martin A
    Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
    Yu AL; Mendelsohn J; Matsumoto SS
    Adv Exp Med Biol; 1986; 195 Pt A():491-6. PubMed ID: 3487920
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploiting biochemical differences in leukemia.
    Coleman MS; Grever MR
    Adv Exp Med Biol; 1984; 165 Pt B():315-20. PubMed ID: 6609538
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
    Prentice HG; Russell NH; Lee N; Ganeshaguru K; Blacklock H; Piga A; Smyth JF; Hoffbrand AV
    Lancet; 1981 Dec; 2(8258):1250-4. PubMed ID: 6118669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
    Riddell S; Johnston JB; Rayner HL; Israels LG
    Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
    Spiers AS; Ruckdeschel JC; Horton J
    Scand J Haematol; 1984 Feb; 32(2):130-4. PubMed ID: 6608139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
    Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
    Spiers AS; Parekh SJ
    Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 40. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
    Spiers AS; Parekh SJ; Bishop MB
    J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.